Search results
Concord Biotech Limited is a R&D driven biopharma Company that manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations.
- About Us
Concord Biotech Limited is a R&D driven biopharma Company...
- R & D
Concord is also working on Contract Research & Manufacturing...
- Facilities
The manufacturing facilities at Concord Biotech are equipped...
- Accreditation
Accreditation - Concord Biotech Limited
- About Us
Concord Biotech Share Price: Find the latest news on Concord Biotech Stock Price. Get all the information on Concord Biotech with historic price charts for NSE / BSE.
- 1,536.55
- 607.08
- 1,528.00
- 39,357
Concord Biotech IPO is a book built issue of Rs 1,551.00 crores, entirely an offer for sale of 2.09 crore shares. The issue was open for subscription from August 4 to August 8, 2023 and got listed on BSE, NSE on August 18, 2023.
- August 8, 2023
- 1482-86, Trasad Road Dholka, Gujarat
- August 4, 2023
Concord Biotech Limited (CBL) is an Indian biotechnology company headquartered in Ahmedabad. The company manufactures fermentation -based biopharmaceutical active pharmaceutical ingredients (APIs) sold worldwide.
Concord Biotech Limited is an R&D based Biotechnology company, having focus on the fermentation, semi-synthetic and synthesis based products. Since its inception in 2000, Concord has recorded an...
People also ask
Who is Concord Biotech Limited?
What is Concord Biotech Ltd share price?
What is the market cap of Concord Biotech Ltd?
What is Concord biotech IPO price band?
6 days ago · Get the latest Concord Biotech share price, financials, recommendations, news and analysis on Economic Times. Concord Biotech is a pharma company with a market cap of Rs 17,614.23 crore and a PE ratio of 57.17.